Cargando…
GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
Increasing evidence supports that ferroptosis plays an important role in tumor growth inhibition. Sorafenib, originally identified as an inhibitor of multiple oncogenic kinases, has been shown to induce ferroptosis in hepatocellular carcinoma (HCC). However, some hepatoma cell lines are less sensiti...
Autores principales: | Wang, Qiujie, Bin, Cheng, Xue, Qiang, Gao, Qingzhu, Huang, Ailong, Wang, Kai, Tang, Ni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8087704/ https://www.ncbi.nlm.nih.gov/pubmed/33931597 http://dx.doi.org/10.1038/s41419-021-03718-4 |
Ejemplares similares
-
GSTZ1‐1 Deficiency Activates NRF2/IGF1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone
por: Yang, Fan, et al.
Publicado: (2019) -
GSTZ1‐1 downregulates Wnt/β‐catenin signalling in hepatocellular carcinoma cells
por: Lei, Chong, et al.
Publicado: (2019) -
GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway
por: Li, Jingjing, et al.
Publicado: (2019) -
Hypermethylation of the Nrf2 Promoter Induces Ferroptosis by Inhibiting the Nrf2-GPX4 Axis in COPD
por: Zhang, Zixiao, et al.
Publicado: (2021) -
Wogonin induces ferroptosis in pancreatic cancer cells by inhibiting the Nrf2/GPX4 axis
por: Liu, Xing, et al.
Publicado: (2023)